Find clinical trials for Lymphoma in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near St Louis, MO, USA:
in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas...
Phase 3
St Louis, Missouri, United States and 16 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
St Louis, Missouri, United States and 68 other locations
order to see how well it works in patients with untreated follicular lymphoma. Mosunetuzumab is an antibody that has been engineered to atta...
Phase 2
St Louis, Missouri, United States
with or without Sonrotoclax in participants with Mantle Cell Lymphoma (MCL).The names of the study drugs involved in this study are:* bendam...
Phase 2
St Louis, Missouri, United States and 6 other locations
of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas...
Phase 1
St Louis, Missouri, United States and 11 other locations
autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to atta...
Phase 1
Saint Louis, Missouri, United States
primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma...
Phase 1
St Louis, Missouri, United States and 4 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Chesterfield, Missouri, United States and 71 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
St Louis, Missouri, United States and 59 other locations
chemotherapy in patients with relapsed/refractory aggressive B cell lymphoma. The hypothesis of this study is that mosunetuzumab can be safe...
Phase 1
St Louis, Missouri, United States
Clinical trials
Research sites
Resources
Legal